Why the study?
Major depressive disorder causes substantial disease burden and impairs quality of life, but predictors of domain-specific quality-of-life changes following acute pharmacological treatment needed identification.
What are the predictors of domain-specific QoL changes in MDD patients following 3 months of pharmacological treatment?
Observational (n=150)
What are the predictors of domain-specific QoL changes in MDD patients following 3 months of pharmacological treatment?
Reductions in depressive symptoms, disability, and pain intensity, along with specific sociodemographic factors, predict improvements in domain-specific quality of life in MDD patients.
Major depressive disorder (MDD) is one of the leading causes of disease burden worldwide and affected patients frequently report impairments in quality of life (QoL). Therefore, the present research aimed to identify predictors of domain-specific QoL changes in MDD patients following the acute phase of pharmacological treatment (3-month). This study is a prospective, naturalistic, and observational analysis on 150 patients. Depressive symptoms, QoL, overall pain intensity, and functionality were assessed using Hamilton Depression Rating Scale, World Health Organization Quality of Life scale-abbreviated version, Visual Analog Scale, and Sheehan Disability Scale, respectively. Reductions in symptom severity and disability were predictors of improvement across all domains of QoL. Pain intensity reduction was a predictor of increases in the physical aspect of QoL. A reduced number of psychiatric hospitalizations and being in a relationship predicted an improvement of QoL in the psychological domain whereas a positive history of suicidal attempts was associated with better social relationships QoL. The predictive models explained 41.2% and 54.7% of the variance in psychological and physical health domains of QoL, respectively. Awareness of sociodemographic and changes in clinical factors that impact the change in domain-specific QoL might help in shaping personalized treatment.
No takes yet. Share an insight, caveat, or question.
Dionisie et al. (2023) conducted an observational in Major depressive disorder (n=150). Clinical and sociodemographic factors was evaluated on Domain-specific QoL changes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: